Teams at Kyverna Therapeutics

The Sr. Director, Clinical Scientist leads clinical research for Multiple Sclerosis therapies, overseeing study execution, protocol development, and cross-functional collaboration in a biotech setting.

Lead global regulatory strategy for Kyverna's cell therapy portfolio across development, approval, and commercialization. Drive labeling strategy, health authority engagements (FDA, EMA), regulatory submissions (INDs, BLAs/MAAs), and cross-functional alignment with Clinical, CMC, Commercial, Market Access, and Legal. Mentor and scale the regulatory team, manage external partners, and provide regulatory input for business development and portfolio decisions to enable launch readiness and lifecycle management.

Lead discovery and early development strategy for next-generation immune cell therapies. Oversee multidisciplinary teams, evaluate and advance in vivo CAR-T and cellular engineering technologies, build external collaborations, prioritize discovery investments, and partner with clinical, regulatory, and business teams to progress candidates from discovery through IND-enabling development.